Clorox (CLX) Q2 2026 earnings review

Stabilization Achieved, But Household Profits Crumble

Clorox has weathered the worst of its ERP transition storm. Q2 Revenue (-1%) and Adjusted EPS (-10%) stabilized after the precipitous drops in Q1. However, the recovery is uneven. While International markets surged, the core U.S. Household segment saw profits collapse by 54% due to manufacturing inefficiencies and volume loss. Management reaffirmed full-year guidance, but the 'transitory' ERP headwinds continue to mask underlying demand issues in key categories like Bags and Wraps.

๐Ÿ‚ Bull Case

International Resilience

The International segment is firing on all cylinders, delivering 5% organic sales growth and a massive 48% jump in Adjusted EBIT. Pricing power and favorable mix are effectively offsetting cost pressures abroad.

ERP Implementation Complete

The operational risk of the U.S. ERP transition is largely in the rearview mirror. With the final phase completed in January, the company can pivot from crisis management to optimization and the integration of the pending GOJO acquisition.

๐Ÿป Bear Case

Household Segment Implosion

Household (Bags, Wraps, Litter) is in distress. Sales fell 6%, but the real shock was the 54% collapse in Adjusted EBIT ($48M to $22M). High manufacturing and logistics costs are eating margins alive in this division.

Gross Margin Contraction

Despite $170M+ equivalent in cost savings (based on run rates), Gross Margin compressed 60bps to 43.2%. Manufacturing and logistics costs (-240bps impact) are outpacing the company's ability to cut costs elsewhere.

โš–๏ธ Verdict: โšช

Neutral. The operational floor is set as the ERP chaos subsides, and the GOJO deal offers a future catalyst. However, the profit collapse in the Household segment and persistent margin pressure prevent a bullish turn. Execution risk remains high.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Household Profitability Collapse

A severe red flag appeared in the Household segment (Glad, Cat Litter). While sales dipped 6%, Segment Adjusted EBIT plummeted 54% YoY. Management cites 'higher manufacturing and logistics costs' and unfavorable mix (shift to larger sizes). This magnitude of profit decline on a single-digit sales drop indicates significant negative operating leverage and potential production inefficiencies.

DRIVER๐ŸŸข

International Momentum

The International segment is the clear standout, accelerating amidst domestic weakness. Sales rose 7% (5% organic) and EBIT surged 48%. The segment is benefiting from strong pricing execution and favorable foreign exchange, serving as a critical hedge against U.S. volume softness.

CONCERN๐Ÿ”ด

Manufacturing Costs vs. Savings

The margin bridge tells a worrying story. Clorox generated significant cost savings (+170 bps), yet Gross Margin still fell 60 bps. Why? Manufacturing & Logistics costs dragged margins down by 240 bps. The company is running hard on efficiency just to stand still against rising operational costs.

THEMEโšช

The ERP Distortion

The fiscal year numbers remain heavily distorted by the ERP transition. FY26 reported sales are guided down 6-10%, but ~7.5 points of this is simply the reversal of inventory ship-ahead from FY25. Investors must look through this 'transitory' $0.90 EPS hit to gauge underlying health, though the noise makes clean analysis difficult.

DRIVERNEW๐ŸŸข

GOJO Acquisition Strategy

Management confirmed the definitive agreement to acquire GOJO Industries (Purell). This moves Clorox deeper into the 'Health and Hygiene' space. While financial impacts are excluded from current guidance, this deal is pivotal for future growth, aiming to reduce reliance on the fluctuating Household segment.

Other KPIs

Adjusted EPS (26Q2)$1.39

Decelerating. Down 10% YoY ($1.55 in 25Q2). The decline reflects lower gross profit and tax rate normalization. While better than the 54% drop in Q1, earnings power remains suppressed by the ERP unwind and operational costs.

Net Cash Provided by Operations (YTD)$404 million

Stable (+1% YoY). Despite earnings volatility, cash generation remains intact. This stability is crucial as Clorox prepares to fund the GOJO acquisition and maintain dividends.

Health and Wellness Sales (26Q2)$643 million

Stabilizing (+2% YoY). Driven by higher volume from ERP stabilization and strong Professional Products shipments. This is a positive signal that the core cleaning business is holding up better than the Household division.

Guidance

FY26 Organic SalesDown 5% to 9%

Stable (Reaffirmed). The negative number is artificial, driven by a 7.5% headwind from the prior year's ERP inventory build. Implicitly, underlying organic performance is flat to slightly down, reflecting a sluggish consumer environment.

FY26 Adjusted EPS$5.95 - $6.30

Stable (Reaffirmed). Represents a 18-23% YoY decline. Includes a massive $0.90 headwinds from the ERP shift. Excluding this one-time distortion, implied earnings power would be ~$7.00, roughly flat vs FY25 ($7.72 adjusted).

FY26 Gross MarginDown 50 to 100 bps

Stable (Reaffirmed). The contraction is driven by the ERP volume reversal (100 bps headwind). Underlying margin expansion from cost savings is being neutralized by logistics inflation.

Key Questions

Household Segment Profitability

Household segment EBIT collapsed 54% on a 6% sales decline. Is this massive deleveraging purely due to temporary ERP logistics costs, or is there a structural pricing/cost mismatch in the Glad and Litter businesses?

Volume vs. Price Mix

Household volume fell 3% and Price Mix fell 3% due to a shift to larger sizes. Does this signal a consumer trade-down that will persist, requiring permanent promotional activity that will cap margins?

GOJO Integration Risks

With the ERP transition just finishing, does the organization have the bandwidth to integrate GOJO immediately without risking the same operational hiccups seen in Q1?